跳至主要内容
临床试验/ACTRN12623000624684
ACTRN12623000624684已完成2 期

A pilot trial of single versus dual diuretic therapy in the intensive care unit

Austin Hospital0 个研究点目标入组 31 人开始时间: 2023年6月7日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
31

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Adults aged 18 years or above
  • Physician decision to administer an intravenous diuretic;
  • Anticipated length of stay of more than 24 hours after intervention administration
  • Existing intra-arterial or central venous catheter
  • Existing indwelling urinary catheter

排除标准

  • Known allergy to furosemide or acetazolamide or other sulphonamides
  • known end-stage renal failure
  • Dose of any diuretic in the preceding 6 hours
  • Significant acid-base disturbance at time of enrolment (pH less than 7.25 or greater than 7.5)
  • Treatment with renal replacement therapy during this intensive care stay
  • Previously enrolled in this study

研究者

发起方
Austin Hospital

相似试验